000 02352 a2200721 4500
005 20250513185245.0
264 0 _c19990913
008 199909s 0 0 eng d
022 _a1359-4184
024 7 _a10.1038/sj.mp.4000522
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSharma, A
245 0 0 _aD4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia.
_h[electronic resource]
260 _bMolecular psychiatry
_cMay 1999
300 _a235-46 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmino Acid Sequence
650 0 4 _aAminopyridines
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBenzazepines
_xpharmacology
650 0 4 _aBinding Sites
650 0 4 _aCHO Cells
650 0 4 _aCarbon Radioisotopes
650 0 4 _aClozapine
_xpharmacology
650 0 4 _aCricetinae
650 0 4 _aDopamine Agonists
_xpharmacology
650 0 4 _aDopamine Antagonists
_xpharmacology
650 0 4 _aDopamine D2 Receptor Antagonists
650 0 4 _aFormates
_xmetabolism
650 0 4 _aGuanosine 5'-O-(3-Thiotriphosphate)
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMethionine
_xmetabolism
650 0 4 _aMutagenesis, Site-Directed
650 0 4 _aNeuroblastoma
650 0 4 _aPhospholipids
_xmetabolism
650 0 4 _aPhosphorylation
650 0 4 _aPiperidines
_xpharmacology
650 0 4 _aPsychotic Disorders
_xmetabolism
650 0 4 _aPyridines
_xpharmacology
650 0 4 _aPyrroles
_xpharmacology
650 0 4 _aRaclopride
650 0 4 _aReceptors, Dopamine D2
_xagonists
650 0 4 _aReceptors, Dopamine D4
650 0 4 _aRecombinant Proteins
_xagonists
650 0 4 _aS-Adenosylmethionine
_xmetabolism
650 0 4 _aSalicylamides
_xpharmacology
650 0 4 _aSchizophrenia
_xmetabolism
650 0 4 _aTransfection
650 0 4 _aTumor Cells, Cultured
700 1 _aKramer, M L
700 1 _aWick, P F
700 1 _aLiu, D
700 1 _aChari, S
700 1 _aShim, S
700 1 _aTan, W
700 1 _aOuellette, D
700 1 _aNagata, M
700 1 _aDuRand, C J
700 1 _aKotb, M
700 1 _aDeth, R C
773 0 _tMolecular psychiatry
_gvol. 4
_gno. 3
_gp. 235-46
856 4 0 _uhttps://doi.org/10.1038/sj.mp.4000522
_zAvailable from publisher's website
999 _c10353502
_d10353502